LANG; Wiegand

Patent Applications and Registrations

Patent applications and USPTO patent grants for LANG; Wiegand.The latest application filed is for "modified coagulation factor viia with extended half-life".

Company Profile

0.13.19

LANG; Wiegand - Colbe DE
Lang; Wiegand - Coelbe DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE App 20170080061 - WEIMER; Thomas ; et al.	2017-03-23
Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life Grant 9,290,561 - Weimer , et al. March 22, 2	2016-03-22
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE App 20140356346 - WEIMER; Thomas ; et al.	2014-12-04
Therapeutic Polypeptides With Increased In Vivo Recovery App 20140248686 - Weimer; Thomas ; et al.	2014-09-04
Modified coagulation factor VIIa with extended half-life Grant 8,765,915 - Weimer , et al. July 1, 2	2014-07-01
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life App 20140072561 - Weimer; Thomas ; et al.	2014-03-13
Therapeutic Polypeptides With Increased In Vivo Recovery App 20130337532 - Weimer; Thomas ; et al.	2013-12-19
Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life Grant 8,575,104 - Weimer , et al. November 5, 2	2013-11-05
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life App 20110183907 - Weimer; Thomas ; et al.	2011-07-28
Mutants of the factor VII-activating protease and detection methods using specific antibodies Grant 7,863,009 - Roemisch , et al. January 4, 2	2011-01-04
Inhibitory monoclonal antibody against blood clotting factor VII-activating protease Grant 7,829,095 - Roemisch , et al. November 9, 2	2010-11-09
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations Grant 7,803,569 - Kiechl , et al. September 28, 2	2010-09-28
Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides App 20100222554 - Weimer; Thomas ; et al.	2010-09-02
Modified Coagulation Factor VIIa With Extended Half-Life App 20090298760 - Weimer; Thomas ; et al.	2009-12-03
Mutants of the factor VII-activating protease and detection methods using specific antibodies App 20090162871 - Roemisch; Juergen ; et al.	2009-06-25
Mutants of the factor VII-activating protease and detection methods using specific antibodies Grant 7,442,514 - Roemisch , et al. October 28, 2	2008-10-28
Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies App 20070231843 - Vey; Martin ; et al.	2007-10-04
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations App 20070099229 - Kiechl; Stefan ; et al.	2007-05-03
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis Grant 7,153,679 - Kiechl , et al. December 26, 2	2006-12-26
Mutants of the factor VII-activating protease and detection methods using specific antibodies App 20050032109 - Roemisch, Juergen ; et al.	2005-02-10
Monoclonal antibody which is specific for activated coagulation factor VII, and its use Grant 6,835,817 - Romisch , et al. December 28, 2	2004-12-28
Mutants of the factor VII-activating protease and detection methods using specific antibodies Grant 6,831,167 - Roemisch , et al. December 14, 2	2004-12-14
Monoclonal antibodies specific for latent antithrombin III and the use thereof App 20040161810 - Roemisch, Juergen ; et al.	2004-08-19
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis App 20040009543 - Kiechl, Stefan ; et al.	2004-01-15
Inhibitory monoclonal antibody against blood clotting factor VII-activating protease App 20030215447 - Roemisch, Juergen ; et al.	2003-11-20
Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies App 20030092094 - Vey, Martin ; et al.	2003-05-15
Mutants of the factor VII-activating protease and detection methods using specific antibodies App 20020142316 - Roemisch, Juergen ; et al.	2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.